TW208007B - - Google Patents
Info
- Publication number
- TW208007B TW208007B TW080108994A TW80108994A TW208007B TW 208007 B TW208007 B TW 208007B TW 080108994 A TW080108994 A TW 080108994A TW 80108994 A TW80108994 A TW 80108994A TW 208007 B TW208007 B TW 208007B
- Authority
- TW
- Taiwan
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/614,326 US5189041A (en) | 1990-11-16 | 1990-11-16 | Tricyclic 5-ht3 receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
TW208007B true TW208007B (zh) | 1993-06-21 |
Family
ID=24460766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW080108994A TW208007B (zh) | 1990-11-16 | 1991-11-15 |
Country Status (17)
Country | Link |
---|---|
US (1) | US5189041A (zh) |
EP (1) | EP0485962A3 (zh) |
JP (1) | JPH04283587A (zh) |
KR (1) | KR920009828A (zh) |
AU (1) | AU8785291A (zh) |
CA (1) | CA2055680A1 (zh) |
FI (1) | FI915400A (zh) |
HU (1) | HUT59406A (zh) |
IE (1) | IE913987A1 (zh) |
IL (1) | IL100061A0 (zh) |
IT (1) | IT1250049B (zh) |
MX (1) | MX9102076A (zh) |
NO (1) | NO914490L (zh) |
PL (1) | PL292419A1 (zh) |
PT (1) | PT99518A (zh) |
TW (1) | TW208007B (zh) |
ZA (1) | ZA919078B (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0430190B1 (en) * | 1989-11-28 | 1995-07-05 | Syntex (U.S.A.) Inc. | New tricyclic compounds |
ES2219813T3 (es) * | 1992-03-12 | 2004-12-01 | Smithkline Beecham Plc | N-(1-nbutil-4-piperidinil)metil-3,4-dihidro-2h-1,3-oxazino-3,2-a-indol-10-carboxamida, o una de sus sales farmaceuticamente aceptables. |
US5852014A (en) * | 1992-03-12 | 1998-12-22 | Smithkline Beecham P.L.C. | Condensed indole derivatives as 5HT4 -receptor antagonists |
MX9305947A (es) * | 1992-09-29 | 1994-06-30 | Smithkline Beecham Plc | Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen. |
ES2113568T3 (es) * | 1993-04-27 | 1998-05-01 | Solvay Fluor & Derivate | Procedimiento para la preparacion de esteres de acidos carboxilicos a partir de halogenuros de acidos carboxilicos y alcoholes. |
US6489355B2 (en) * | 1993-12-01 | 2002-12-03 | Eli Lilly And Company | Methods of inhibiting the effects of amyloidogenic proteins |
US5723103A (en) * | 1994-12-09 | 1998-03-03 | Vanderbilt University | Substituted benzamides and radioligand analogs and methods of use |
IT1303123B1 (it) * | 1998-10-13 | 2000-10-30 | Rotta Research Lab | Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed |
JP2004502642A (ja) * | 2000-02-11 | 2004-01-29 | ブリストル−マイヤーズ スクイブ カンパニー | カンナビノイドレセプターモジュレーター、それらの製造方法、および呼吸系および非呼吸系疾患の処置のためのカンナビノイドレセプターモジュレーターの使用 |
AU2001261606A1 (en) * | 2000-05-18 | 2001-11-26 | Glaxo Group Limited | Method for treating functional dyspepsia |
AR036041A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen |
AR036040A1 (es) | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
EP1442037A1 (en) | 2001-11-09 | 2004-08-04 | PHARMACIA & UPJOHN COMPANY | Azabicyclic-phenyl-fused-heterocyclic compounds and their use as alpha7 nachr ligands |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
DE10234424A1 (de) | 2002-07-29 | 2004-02-12 | Bayer Ag | Benzothiophen-, Benzofuran- und Indolharnstoffe |
TWI355936B (en) | 2003-02-18 | 2012-01-11 | Helsinn Healthcare Sa | Uses of palonosetron hydrochloride |
ITMI20031467A1 (it) * | 2003-07-18 | 2005-01-19 | Acraf | Farmaco attivo nel dolore neuropatico |
ES2396300T3 (es) | 2008-11-19 | 2013-02-20 | Envivo Pharmaceuticals, Inc. | Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma |
US9145396B2 (en) | 2008-12-01 | 2015-09-29 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine |
WO2011146511A1 (en) | 2010-05-17 | 2011-11-24 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2121394A1 (fr) * | 1971-01-08 | 1972-08-25 | Anvar | Procédé d'obtention de dérivés d'acides indole carboxyliques et produits préparables par ce procédé. |
JPS5337696A (en) * | 1976-08-26 | 1978-04-06 | Omnium Chimique Sa | Hexahydrocantinonee6 derivative |
FR2475394A1 (fr) * | 1980-02-12 | 1981-08-14 | Synthelabo | Compositions pharmaceutiques contenant l'hexahydro-1, 2, 3, 3a, 4, 5, 6h indolo (3, 2, 1 - d. e) (1, 5) naphtyridinone - 6 |
FR2531083B1 (fr) * | 1982-06-29 | 1986-11-28 | Sandoz Sa | Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments |
GB8623142D0 (en) * | 1986-09-26 | 1986-10-29 | Beecham Group Plc | Compounds |
JP2765845B2 (ja) * | 1986-11-21 | 1998-06-18 | グラクソ、グループ、リミテッド | 中止症候群の予防の治療薬 |
ATE111910T1 (de) * | 1987-09-03 | 1994-10-15 | Glaxo Group Ltd | Lactamderivate. |
DE3810552A1 (de) * | 1988-03-29 | 1989-10-19 | Sandoz Ag | Ester und amide von indol-, benzo(b)thiopen-, benzo(b)furancarbonsaeuren oder 4-amino-2-methoxy-benzolsaeuren mit n-heterocyclischen oder n-heterobicyclischen alkoholen oder aminen, verfahren zu deren herstellung sie enthaltende pharmazeutische zusammensetzungen sowie applikator zur verabreichung derselben |
EP0356098A3 (en) * | 1988-08-15 | 1990-07-25 | Glaxo Group Limited | Lactam derivatives |
EP0377238A1 (en) * | 1988-12-22 | 1990-07-11 | Duphar International Research B.V | New annelated indolo (3,2-c)-lactams |
GB8904551D0 (en) * | 1989-02-28 | 1989-04-12 | Glaxo Group Ltd | Chemical compounds |
KR900013959A (ko) * | 1989-03-13 | 1990-10-22 | 원본미기재 | γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물 |
JPH02290878A (ja) * | 1989-04-28 | 1990-11-30 | Ono Pharmaceut Co Ltd | ベンゾチエノ(フロ)ピリジン誘導体 |
-
1990
- 1990-11-16 US US07/614,326 patent/US5189041A/en not_active Expired - Fee Related
-
1991
- 1991-11-05 KR KR1019910020330A patent/KR920009828A/ko not_active Application Discontinuation
- 1991-11-12 EP EP19910119290 patent/EP0485962A3/en not_active Withdrawn
- 1991-11-12 IT ITTO910865A patent/IT1250049B/it active IP Right Grant
- 1991-11-15 TW TW080108994A patent/TW208007B/zh active
- 1991-11-15 CA CA002055680A patent/CA2055680A1/en not_active Abandoned
- 1991-11-15 JP JP3300234A patent/JPH04283587A/ja active Pending
- 1991-11-15 IE IE398791A patent/IE913987A1/en not_active Application Discontinuation
- 1991-11-15 ZA ZA919078A patent/ZA919078B/xx unknown
- 1991-11-15 PL PL29241991A patent/PL292419A1/xx unknown
- 1991-11-15 IL IL100061A patent/IL100061A0/xx unknown
- 1991-11-15 FI FI915400A patent/FI915400A/fi not_active Application Discontinuation
- 1991-11-15 MX MX9102076A patent/MX9102076A/es unknown
- 1991-11-15 NO NO91914490A patent/NO914490L/no unknown
- 1991-11-15 PT PT99518A patent/PT99518A/pt not_active Application Discontinuation
- 1991-11-15 HU HU913579A patent/HUT59406A/hu unknown
- 1991-11-15 AU AU87852/91A patent/AU8785291A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL292419A1 (en) | 1993-04-05 |
ITTO910865A0 (it) | 1991-11-12 |
FI915400A (fi) | 1992-05-17 |
ZA919078B (en) | 1993-05-17 |
FI915400A0 (fi) | 1991-11-15 |
IL100061A0 (en) | 1992-08-18 |
IE913987A1 (en) | 1992-05-20 |
US5189041A (en) | 1993-02-23 |
PT99518A (pt) | 1992-09-30 |
AU8785291A (en) | 1992-05-21 |
EP0485962A3 (en) | 1992-07-29 |
KR920009828A (ko) | 1992-06-25 |
NO914490L (no) | 1992-05-18 |
EP0485962A2 (en) | 1992-05-20 |
MX9102076A (es) | 1992-07-08 |
ITTO910865A1 (it) | 1992-05-17 |
HUT59406A (en) | 1992-05-28 |
JPH04283587A (ja) | 1992-10-08 |
IT1250049B (it) | 1995-03-30 |
HU913579D0 (en) | 1992-01-28 |
CA2055680A1 (en) | 1992-05-17 |
NO914490D0 (no) | 1991-11-15 |